Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Amortization of Deferred Charges (2010 - 2024)

Analysis

Cerenome (CNSY) Amortization of Deferred Charges (2010 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn -
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn
10 Cerenome 20.42 Mn 11.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 4,000.00
Mar 31, 2024 16,000.00
Dec 31, 2023 30,000.00
Sep 30, 2023 41,000.00
Jun 30, 2023 53,000.00
Mar 31, 2023 66,000.00
Dec 31, 2022 80,000.00
Sep 30, 2022 91,000.00
Jun 30, 2022 103,000.00
Mar 31, 2022 115,000.00
Dec 31, 2021 129,000.00
Sep 30, 2021 134,000.00
Jun 30, 2021 132,000.00
Mar 31, 2021 151,000.00
Dec 31, 2020 156,000.00
Sep 30, 2020 153,000.00
Jun 30, 2020 153,000.00
Mar 31, 2020 122,000.00
Dec 31, 2019 196,000.00
Sep 30, 2019 97,000.00